| Literature DB >> 28706236 |
Feng Luo1, Zixuan Zhong1, Li Liu1, Yasuo Igarashi1, Deti Xie1, Nannan Li2.
Abstract
Interspecific fungal antagonism occurred commonly in the interaction zone of different white rot fungi. This competitive interaction could markedly influence the metabolic pathway of intracellular metabolites, which was associated with the fungal morphology change and growth restriction. So far, it remains unknown on intracellular metabolite regulation during fungal competitive interaction. Herein, we performed the metabolomic analysis of the in vivo metabolite changes during competitive interaction between each two of the three white rot fungi Trametes versicolor, Pleurotus ostreatus and Dichomitus squalens and identified differential metabolites in the interaction zone compared to each two isolates. Many metabolites in the carnitine, lipid, ethylene and trehalose metabolic pathways were significantly up-regulated. These metabolic pathways are all involved in defensive response to abiotic and/or biotic stressful condition.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28706236 PMCID: PMC5509712 DOI: 10.1038/s41598-017-05669-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Paired-culture on Sc agar plate among Tv, Ds and Po.
Figure 2Significant changes of compounds in each interaction zone compare to the two isolates. Ratios as: up-regulated numbers/down-regulated numbers, p-value ≤ 0.05 was taken as significant.
Figure 3Summary of the pathway-level increase (red box) and decrease (green box) of metabolism in three interaction zones with significant data combined from synergistically changed metabolites compared to both isolates. Pathways in yellow and white fonts represent unique and shared pathways, respectively.
Figure 4Synergistic changes in all three interaction zones relative to both isolates. Red arrow means increase, green arrow means decrease.
Statistically significant metabolites in all interactions.
| Super Pathway | Sub Pathway | Biochemical Name | Fold Change | |||||
|---|---|---|---|---|---|---|---|---|
| TvDs/Tv | TvDs/Ds | TvPo/Tv | TvPo/Po | PoDs/Ds | PoDs/Po | |||
| Amino acid | Branched Chain Amino Acids (pyruvate derived) | 2-methylbutyrylcarnitine (C5) | 3.6 | 2.61 | 3.27 | 2.05 | 3.8 | 3.28 |
| Branched Chain Amino Acids (pyruvate derived) | isobutyrylcarnitine | 14.57 | 4.6 | 12.13 | 1.82 | 7.93 | 3.76 | |
| Branched Chain Amino Acids (pyruvate derived) | propionylcarnitine | 2.64 | 3.91 | 5.24 | 2.05 | 9.73 | 2.58 | |
| Aromatic amino acid metabolism (PEP derived) | tryptophan | 6.29 | 11.04 | 8.18 | 119.94 | 8.58 | 71.73 | |
| Carbohydrate | Glycolysis | Isobar: hexose diphosphates | 8.42 | 4.03 | 15.44 | 7.41 | 3.66 | 3.67 |
| Amino sugar and nucleotide sugar | N-acetylglucosamine |
|
|
|
|
|
| |
| Cofactors, Prosthetic Groups, Electron Carriers | Carnitine metabolism | carnitine | 4.09 | 1.6 | 3.36 | 2.1 | 1.65 | 2.63 |
| Oxidative phosphorylation | methylphosphate | 6.8 | 5.92 | 4.41 | 4.67 | 2.85 | 3.47 | |
| Nicotinate and nicotinamide metabolism | nicotinamide adenine dinucleotide (NAD+) | 8.27 | 5.38 | 9.35 | 2.56 | 4.15 | 1.74 | |
| Riboflavin and FAD metabolism | riboflavin (Vitamin B2) | 3.99 | 2.88 | 2.41 | 2.07 | 2.24 | 2.67 | |
| Lipids | Glycerolipids | 1-linoleoylglycerol (1-monolinolein) | 5.39 | 5.39 | 5.38 | 2.85 | 4.97 | 2.63 |
| Phospholipids | 1-linoleoylglycerophosphoethanolamine* | 11.64 | 2.86 | 12.46 | 4.13 | 2.61 | 3.52 | |
| Phospholipids | 1-linoleoylglycerophosphoinositol* | 16.2 | 3.35 | 14.45 | 8.93 | 2.58 | 7.7 | |
| Glycerolipids | 2-linoleoylglycerol (2-monolinolein) | 5.7 | 9.52 | 4.26 | 5.8 | 5.23 | 4.25 | |
| Carnitine metabolism | acetylcarnitine | 1.47 | 2.5 | 2.28 | 2.29 | 3.27 | 1.93 | |
| Phospholipids | glycerophosphorylcholine (GPC) | 1.54 | 1.24 | 1.64 | 2.34 | 1.31 | 2.3 | |
| Carnitine metabolism | hydroxybutyrylcarnitine* | 3.91 | 2.19 | 4.2 | 2.78 | 3.25 | 3.84 | |
Figure 5Carnitine esters significantly increase in all interaction zones. (A) Carnitine; (B) Hydroxybutyrylcarnitine; (C) Acetylcarnitine; (D) Propionylcarnitine; (E) isobutyrylcarnitine; (F) 2-methylbutyrylcarnitine.
Figure 6Lipolysis products significantly increase in all interaction zones. (A) 1-linoleoylglycerol; (B) 1-linoleoyl-GPE; (C) 1-linoleoyl-GPI; (D) glycerophosphocholine (GPC).
Figure 7The metabolites only significantly increase in two interactions. (A) 1-aminocyclopropanecarbolylic acid (ACC); (B) Trehalose-6-phosphate, (C) UDP-glucose, (D) UDP-galactose.